Mylan NV (MYL)

31.30
NASDAQ : Health Care
Prev Close 31.24
Day Low/High 30.69 / 31.45
52 Wk Low/High 29.39 / 45.87
Avg Volume 6.33M
Exchange NASDAQ
Shares Outstanding 536.28M
Market Cap 16.75B
EPS 1.80
P/E Ratio 25.19
Div & Yield N.A. (N.A)

Latest News

FDA Official Calls for Ending Codeine Use in Kids Cough Products

FDA Official Calls for Ending Codeine Use in Kids Cough Products

An FDA advisory panel recommends that warnings on cough syrups be extended from young children to everyone under 18.

Will Allergan's Deal With Tribe Hold Up?

Will Allergan's Deal With Tribe Hold Up?

Answering questions from the biotech mailbag.

Trading Mylan: Look Out for This Key Level

Trading Mylan: Look Out for This Key Level

A retest of MYL's recent low is an important area.

Big Drug Makers Could Face More Pressure on Codeine Remedies for Kids

Big Drug Makers Could Face More Pressure on Codeine Remedies for Kids

A small portion of the population is prone to "ultra-metabolize" codeine at rates far in excess of the general population.

Mylan Can Focus on New Generics After EpiPen Medicaid Settlement

Mylan Can Focus on New Generics After EpiPen Medicaid Settlement

Mylan has finalized a $465M settlement with the U.S. DOJ and other government agencies over the classification of its EpiPen auto injectors in the Medicaid Drug Rebate Program.

What You Should Know About One of Wall Street's Most Legendary Villains

What You Should Know About One of Wall Street's Most Legendary Villains

Carl Icahn has had quite the career.

How Activist Carl Icahn Became the 'Corporate Raider' We Know Today

How Activist Carl Icahn Became the 'Corporate Raider' We Know Today

"If you need a friend, get a dog."

Barcelona Terror Attack: Manhunt Is Underway

Barcelona Terror Attack: Manhunt Is Underway

13 people are dead and 100 injured in the terror attack at a popular tourist spot in Barcelona.

Mylan Finalizes $465 Million EpiPen Settlement With DoJ

Mylan Finalizes $465 Million EpiPen Settlement With DoJ

The dispute became the center of a drug price firestorm.

A Measured Fed and Retail Relief Rally Give Wall Street a Small Lift

A Measured Fed and Retail Relief Rally Give Wall Street a Small Lift

The Fed and retail drive markets on Wednesday.

Stocks Inch Higher as Fed Signals September as Start of Balance Sheet Reduction

Stocks Inch Higher as Fed Signals September as Start of Balance Sheet Reduction

Target and Urban Outfitters sweetened investor appetite for retail names.

Midday Report: Target Leads Retail; Dow Returns Above 22,000

Midday Report: Target Leads Retail; Dow Returns Above 22,000

Strong quarterly performances from Target Corp. and Urban Outfitters Inc. inspired broader retail gains.

Stocks Higher as Target, Urban Outfitters Rise, Wall Street Waits for Fed

Stocks Higher as Target, Urban Outfitters Rise, Wall Street Waits for Fed

Target and Urban Outfitters sweetened investor appetite for retail names.

Doesn't Take Long to Be Bullish

Russell 2000 has best day since June 1 and transports bounce.

Mylan Badly Needs Help from FDA to Escape its Woes and Deliver These Key Drugs

Mylan Badly Needs Help from FDA to Escape its Woes and Deliver These Key Drugs

Mylan execs have criticized the FDA, which they say has been too slow to approve competitors to complex drugs.

Opioid Makers Buffeted by Trump's Declaration of Addiction Crisis

Opioid Makers Buffeted by Trump's Declaration of Addiction Crisis

The companies are subject to either state, federal or congressional inquiries into their marketing practices for prescription opioids, which are blamed for helping to fuel rising numbers or addicted individuals.

The New #15 Most Shorted Nasdaq 100 Component: Mylan

The most recent short interest data has been released for the 07/31/2017 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the Nasdaq 100 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

North Korea's War of Words With Trump Drags Wall Street Over a Cliff

North Korea's War of Words With Trump Drags Wall Street Over a Cliff

All three major U.S. indexes declined.

What Mylan Has in Common With the Word Disaster

What Mylan Has in Common With the Word Disaster

Mylan might be trapping the bears here in a big way.

Mylan Slides on North American Sales Drop, Uncertainty over Generic Approvals

Mylan Slides on North American Sales Drop, Uncertainty over Generic Approvals

North America segment third-party net sales were $1.28B during the second quarter.

Midday Report: Disney Weighs on Dow; North Korea Tensions Pull Markets Lower

Midday Report: Disney Weighs on Dow; North Korea Tensions Pull Markets Lower

Wall Street pulled lower mid-week on worries over rising tensions between the U.S. and North Korea.

North Korea Threat Pulls Wall Street Lower

North Korea Threat Pulls Wall Street Lower

The North Korea threat pulls Wall Street into the red.

These Two Biotech Stocks Are Going Berserk on Wednesday

These Two Biotech Stocks Are Going Berserk on Wednesday

And then there is Mylan.

TheStreet Quant Rating: C (Hold)